Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence

References

• HirschATHaskalZJHertzerNRAmerican Association for Vascular SurgerySociety for Vascular SurgerySociety for Cardiovascular Angiography and InterventionsSociety for Vascular Medicine and BiologySociety of Interventional RadiologyACC/AHA Task Force on Practice GuidelinesAmerican Association of Cardiovascular and Pulmonary RehabilitationNational Heart, Lung, and Blood InstituteSociety for Vascular NursingTransAtlantic Inter-Society ConsensusVascular Disease FoundationACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease FoundationJ Am Coll Cardiol200611311e463e654
   Google Scholar
• RookeTWHirschATMisraSSociety for Cardiovascular Angiography and InterventionsSociety of Interventional RadiologySociety for Vascular MedicineSociety for Vascular Surgery2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol201158192020204521963765
   PubMed Web of Science ®Google Scholar
• European Stroke OrganisationTenderaMAboyansVESC Committee for Practice Guidelines. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)Eur Heart J201132222851290621873417
   PubMed Web of Science ®Google Scholar
• GoodneyPPBeckAWNagleJWelchHGZwolakRMNational trends in lower extremity bypass surgery, endovascular interventions, and major amputationsJ Vasc Surg2009501546019481407
   PubMed Web of Science ®Google Scholar
• ScheinertDScheinertSSaxJPrevalence and clinical impact of stent fractures after femoropopliteal stentingJ Am Coll Cardiol200545231231515653033
   PubMed Web of Science ®Google Scholar
• BosiersMTorselloGGisslerHMNitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I studyJ Endovasc Ther200916326126919642788
   PubMed Web of Science ®Google Scholar
• BosiersMDelooseKCallaertJResults of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesionsJ Vasc Surg20115441042105021636239
   PubMed Web of Science ®Google Scholar
• DavaineJMAzémaLGuyomarchBOne-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA “STEnting Long de L’Artère fémorale superficielle” cohort)Eur J Vasc Endovasc Surg201244443244122920949
   PubMed Web of Science ®Google Scholar
• FDASupera Peripheral Stent System: Instruction for use Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf12/P120020b.pdfAccessed May 21, 2015
   Google Scholar
• ScheinertDGrummtLPiorkowskiMA novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registryJ Endovasc Ther201118674575222149221
   PubMed Web of Science ®Google Scholar
• GarciaLJaffMRMetzgerCSUPERB Trial Investigators*Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trialCirc Cardiovasc Interv201585e00093725969545
   PubMed Web of Science ®Google Scholar
• WernerMPaetzoldABanning-EichenseerUTreatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registryEuroIntervention201410786186824682531
   PubMed Web of Science ®Google Scholar
• DumantepeMSerenMFazlıogullariOAyogluUTeymenBTreatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm resultsVascular2015 Epub ahead of print
   PubMedGoogle Scholar
• ChanYCChengSWTingACCheungGCPrimary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stentsJ Vasc Surg201459238439124461862
   PubMed Web of Science ®Google Scholar
• GeorgeJCRosenESNachtigallJVanHiseAKovachRSUPERA interwoven nitinol stent outcomes in above-knee IntErventions (SAKE) studyJ Vasc Interv Radiol201425695496124768325
   PubMed Web of Science ®Google Scholar
• LairdJRKatzenBTScheinertDRESILIENT InvestigatorsNitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trialCirc Cardiovasc Interv20103326727620484101
   PubMed Web of Science ®Google Scholar
• DakeMDAnselGMJaffMRZilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study resultsCirc Cardiovasc Interv20114549550421953370
   PubMed Web of Science ®Google Scholar
• GeraghtyPJMewissenMWJaffMRAnselGMVIBRANT InvestigatorsThree-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive diseaseJ Vasc Surg2013582386395e423676191
   PubMed Web of Science ®Google Scholar
• WernerMPiorkowskiMThiemeMSUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segmentJ Endovasc Ther201320675976624325691
   PubMed Web of Science ®Google Scholar
• LairdJRJainAZellerTComplete SE Investigators. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trialJ Endovasc Ther201421220221224754279
   PubMed Web of Science ®Google Scholar
• ScheinertDWernerMScheinertSTreatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stentJACC Cardiovasc Interv201361657123347863
   PubMed Web of Science ®Google Scholar
• BresciaAAWickersBMCorreaJCSmedsMRJacobsDLStenting of femoropopliteal lesions using interwoven nitinol stentsJ Vasc Surg20156161472147825752693
   PubMed Web of Science ®Google Scholar
• GoltzJPRitterCOKellersmannRKleinDHahnDKickuthREndovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial forceJ Endovasc Ther201219345045622788900
   PubMed Web of Science ®Google Scholar
• LeónLRJrDieterRSGaddCLPreliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal arteryJ Vasc Surg20135741014102223535039
   PubMed Web of Science ®Google Scholar